This fact sheet answers frequently asked questions about dolutegravir, a new antiretroviral available in generic form in low- and middle-income countries. Topics include transitioning to new treatment options, pricing and supply chain risks, among others.
Fact Sheet: The Dolutegravir Opportunity: Frequently Asked Questions
October 27, 2017
September 26, 2019